TLR signaling-induced CD103-expressing cells protect against intestinal inflammation

Inflammatory Bowel Diseases

Volumn 21, Issue 3, 2015, Pages 507-519

  Wittmann, Alexandra ^a,b   Bron, Peter A ^c,d   Van Swam, Iris I ^c,d   Kleerebezem, Michiel ^c,d,e   Adam, Patrick ^f   Gronbach, Kerstin ^a   Menz, Sarah ^a   Flade, Isabell ^a   Bender, Annika ^a   Schäfer, Andrea ^a   Korkmaz, Ali Giray ^a   Parusel, Raphael ^a   Autenrieth, Ingo B ^a   Frick, Julia Stefanie ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^c NIZO FOOD RESEARCH   (Netherlands)

^d TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^e WAGENINGEN UNIVERSITY   (Netherlands)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

bone marrow chimeric mice; DSS; intestinal Toll like receptors; lamina propria dendritic cells

Indexed keywords

CD103 ANTIGEN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; ALPHA E INTEGRINS; ALPHA INTEGRIN; DEXTRAN SULFATE; LEUKOCYTE ANTIGEN; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIA; BONE MARROW; CELL PROTECTION; DENDRITIC CELL; ENTERITIS; EPITHELIUM CELL; EXPERIMENTAL MODEL; FEEDING; FEMALE; HEMATOPOIETIC CELL; INTESTINAL DENDRITIC CELL; LAMINA PROPRIA; MALE; MESENTERY LYMPH NODE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COLITIS; COMPLICATION; CYTOLOGY; DISEASE MODEL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FLOW CYTOMETRY; IMMUNOLOGY; INFLAMMATION; INTESTINE; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD; COLITIS; DENDRITIC CELLS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLOW CYTOMETRY; INFLAMMATION; INTEGRIN ALPHA CHAINS; INTESTINES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84923456594     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000292     Document Type: Article

References (54)

1. Niess JH, Brand S, Gu X, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science. 2005; 307: 254-258.
2. Lelouard H, Fallet M, de Bovis B, et al. Peyer's patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores. Gastroenterology. 2012; 142: 592-601 e593.
3. Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol. 2007; 25: 381-418.
4. Kraehenbuhl JP, Neutra MR. Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol. 2000; 16: 301-332.
5. McDole JR, Wheeler LW, McDonald KG, et al. Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature. 2012; 483: 345-349.
6. Inaba K, Inaba M, Naito M, et al. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med. 1993; 178: 479-488.
7. Svensson M, Stockinger B, Wick MJ. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J Immunol. 1997; 158: 4229-4236.
8. Sallusto F, Cella M, Danieli C, et al. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995; 182: 389-400.
9. Pierre P, Turley SJ, Gatti E, et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature. 1997; 388: 787-792.
10. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol. 2005; 23: 975-1028.
11. Muller M, Fink K, Geisel J, et al. Intestinal colonization of IL-2 deficient mice with non-colitogenic B. vulgatus prevents DC maturation and T-cell polarization. PLoS One. 2008; 3: e2376.
12. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010; 11: 373-384.
13. Bron PA, van Baarlen P, Kleerebezem M. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol. 2012; 10: 66-78.
14. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000; 68: 7010-7017.
15. Hausmann M, Kiessling S, Mestermann S, et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology. 2002; 122: 1987-2000.
16. Hart AL, Al-Hassi HO, Rigby RJ, et al. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology. 2005; 129: 50-65.
17. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cellule. 2004; 118: 229-241.
18. Perse M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol. 2012; 2012: 718617.
19. Melgar S, Karlsson L, Rehnstrom E, et al. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol. 2008; 8: 836-844.
20. Berndt BE, Zhang M, Chen GH, et al. The role of dendritic cells in the development of acute dextran sulfate sodium colitis. J Immunol. 2007; 179: 6255-6262.
21. Qualls JE, Tuna H, Kaplan AM, et al. Suppression of experimental colitis in mice by CD11c+ dendritic cells. Inflamm Bowel Dis. 2009; 15: 236-247.
22. Bron PA, Tomita S, van S II, et al. Lactobacillus plantarum possesses the capability for wall teichoic acid backbone alditol switching. Microb Cell Fact. 2012; 11: 123.
23. Grangette C, Nutten S, Palumbo E, et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A. 2005; 102: 10321-10326.
24. Bainbridge BW, Coats SR, Pham TT, et al. Expression of a Porphyromonas gingivalis lipid A palmitylacyltransferase in Escherichia coli yields a chimeric lipid A with altered ability to stimulate interleukin-8 secretion. Cell Microbiol. 2006; 8: 120-129.
25. Park BS, Song DH, Kim HM, et al. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature. 2009; 458: 1191-1195.
26. Lambert JM, Bongers RS, Kleerebezem M. Cre-lox-based system for multiple gene deletions and selectable-marker removal in Lactobacillus plantarum. Appl Environ Microbiol. 2007; 73: 1126-1135.
27. Krajina T, Leithauser F, Reimann J. MHC class II-independent CD25+ CD4+ CD8alpha beta+ alpha beta T cells attenuate CD4+ T cell-induced transfer colitis. Eur J Immunol. 2004; 34: 705-714.
28. Wittmann A, Autenrieth IB, Frick JS. Plasmacytoid dendritic cells are crucial in bifidobacterium adolescentis-mediated Inhibition of Yersinia enterocolitica infection. PLoS One. 2013; 8: e71338.
29. Husebye H, Halaas O, Stenmark H, et al. Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J. 2006; 25: 683-692.
30. Geisel J, Kahl F, Muller M, et al. IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist tolerance and cross-tolerance in dendritic cells. J Immunol. 2007; 179: 5811-5818.
31. Annacker O, Coombes JL, Malmstrom V, et al. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med. 2005; 202: 1051-1061.
32. Frank DN, Pace NR. Gastrointestinal microbiology enters the metagenomics era. Curropin Gastroenterol. 2008; 24: 4-10.
33. Rath HC, Schultz M, Freitag R, et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun. 2001; 69: 2277-2285.
34. Martin M, Katz J, Vogel SN, et al. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J Immunol. 2001; 167: 5278-5285.
35. Tauber SC, Nau R. Immunomodulatory properties of antibiotics. Curr Mol Pharmacol. 2008; 1: 68-79.
36. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010; 28: 573-621.
37. Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrateproducing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014; 63: 1275-1283.
38. Hornef MW, Frisan T, Vandewalle A, et al. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J Exp Med. 2002; 195: 559-570.
39. Hornef MW, Normark BH, Vandewalle A, et al. Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med. 2003; 198: 1225-1235.
40. Kagan JC, Su T, Horng T, et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol. 2008; 9: 361-368.
41. Chabot S, Wagner JS, Farrant S, et al. TLRs regulate the gatekeeping functions of the intestinal follicle-Associated epithelium. J Immunol. 2006; 176: 4275-4283.
42. Vaishnava S, Behrendt CL, Ismail AS, et al. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A. 2008; 105: 20858-20863.
43. Dubuquoy L, Jansson EA, Deeb S, et al. Impaired expression of peroxisome proliferator-Activated receptor gamma in ulcerative colitis. Gastroenterology. 2003; 124: 1265-1276.
44. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology. 2007; 132: 1359-1374.
45. Fukata M, Chen A, Klepper A, et al. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology. 2006; 131: 862-877.
46. Waidmann M, Bechtold O, Frick JS, et al. Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology. 2003; 125: 162-177.
47. Sporri R, Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol. 2005; 6: 163-170.
48. Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol. 2006; 6: 476-483.
49. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature. 2007; 447: 972-978.
50. Yanagawa Y, Onoe K. Enhanced IL-10 production by TLR4-And TLR2-primed dendritic cells upon TLR restimulation. J Immunol. 2007; 178: 6173-6180.
51. Varol C, Vallon-Eberhard A, Elinav E, et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity. 2009; 31: 502-512.
52. Bogunovic M, Ginhoux F, Helft J, et al. Origin of the lamina propria dendritic cell network. Immunity. 2009; 31: 513-525.
53. Coombes JL, Siddiqui KR, rancibia-Carcamo CV, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med. 2007; 204: 1757-1764.
54. Matteoli G, Mazzini E, Iliev ID, et al. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/ T effector cell balance and oral tolerance induction. Gut. 2010; 59: 595-604.